Chemotherapy

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with HER2-positive breast cancer, according to long-term results of a randomized phase 3 trial.

Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to results of a retrospective study.

SAN ANTONIO — The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response for certain patients with triple-negative breast cancer.

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia.

Music may help improve cognitive function among people undergoing chemotherapy, according to results of a preliminary study.

Early receipt of palliative care appeared linked to less aggressive end-of-life care for women with ovarian cancer, according to study results.

Common treatments for breast cancer — including chemotherapy, radiation and surgery — may accelerate biological aging among breast cancer survivors, according to results of a longitudinal, observational study.

SAN DIEGO — Anitocabtagene autoleucel exhibited durable efficacy among heavily pretreated patients with high-risk relapsed or refractory multiple myeloma, results of the phase 2 iMMagine-1 study showed.

The role of AI in oncology and hematology expanded dramatically in 2024.

The FDA granted an encorafenib-led combination accelerated approval for the treatment of certain patients with metastatic colorectal cancer.